Advicenne, a biotech company poised for Euronext listing, is seeking market-ready partners and EUR 40 million VC funds at Biotech Showcase 2017. Led by Didier Laurens, Advicenne's innovative approach is highlighted in Le Journal Des Biotechs. Jamila El Bougrini Invest Securities joins the quest, highlighting Advicenne's growth potential.